Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease
Celiac disease (CD) is a systemic disease that primarily affects the small intestine. The presence of anti-tissue transglutaminase 2 (anti-TG2) antibodies in the serum, as well as the presence of autoimmune phenomena, account for the inclusion of CD among autoimmune diseases. Anti-TG2 autoantibodies...
Main Authors: | Mariantonia Maglio, Riccardo Troncone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnut.2020.00073/full |
Similar Items
-
Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease
by: Mariantonia Maglio, et al.
Published: (2017-09-01) -
Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
by: Stefania Martucciello, et al.
Published: (2020-05-01) -
Prevalence of celiac disease in Shiraz, southern Iran
by: Saberi-Firouzi Mehdi, et al.
Published: (2008-01-01) -
Daño hepático y enfermedad celíaca Liver damage and celiac disease
by: M. D. Cantarero Vallejo, et al.
Published: (2007-11-01) -
TG6 Auto-Antibodies in Dermatitis Herpetiformis
by: Marios Hadjivassiliou, et al.
Published: (2020-09-01)